Methylphenidate (Methylphenidale)

Methylphenidate: description, use and side effects

Methylphenidate is a sympathomimetic drug that has a stimulating effect on the central nervous system. The drug is used to treat hyperkinetic syndrome in children, to improve mental activity in recovering patients and in patients with certain types of depression, as well as to relieve a person from lethargy, which can develop after taking certain medications.

Methylphenidate is given orally in tablet form or by injection. Ritalin is the trade name for methylphenidate. The drug was approved for medical use in the United States in 1955 and has since become widely used in the treatment of various mental disorders.

Hyperkinetic syndrome (HKS) is one of the main indications for the use of methylphenidate. GCS is a disorder that involves hyperactivity, inability to control one's actions, and problems concentrating. Methylphenidate helps improve concentration, reduce hyperactivity, and improve academic performance in children with GCS.

Methylphenidate may also be used to improve mental performance in patients who have suffered a stroke or traumatic brain injury. The drug may help improve memory, attention, and other cognitive functions.

Methylphenidate can also be used in the treatment of depression, especially those forms that are accompanied by drowsiness and fatigue. The drug helps improve mood and increase energy in patients with depression.

Although methylphenidate is effective in treating various mental disorders, the drug may cause side effects. Some of these may include nervousness, insomnia, loss of appetite, headache, nausea and abdominal pain. These side effects are usually temporary and go away when you stop taking the drug.

In conclusion, Methylphenidate is an effective drug that can help patients with hyperkinetic syndrome, improve mental performance in recovering patients and in patients with certain types of depression. Although the drug may cause side effects, its use should be considered in terms of benefits and risks for each patient.

Methylphenidate (Methyldene or Methylphenidate) is a sympathomimetic drug that has a stimulating effect on the central nervous system. It is widely used to treat children with hyperkinetic syndrome, improve mental performance in patients suffering from post-infarction cardiomyopathy and in the treatment of depression. The drug was first developed in Germany in 1934; in subsequent years, many studies were carried out in various European countries. Research was mainly aimed at developing precise dosing methods and studying

Methylphenidate

Currently, methylphenate is used for the treatment and prevention of attention deficit hyperactivity disorder, including nootropic and neuroprotective effects; for mental stimulation, revitalization of attention and improvement of learning ability; in the treatment of depressive disorders and fatigue (fatigue and depression) of varying severity.